Status:
COMPLETED
Extracorporeal Shock Wave Treatment - Can the Pain be Reduced?
Lead Sponsor:
University of Zurich
Conditions:
Fasciitis, Plantar
Achillodynia
Eligibility:
All Genders
18+ years
Brief Summary
Patients with Fascititis plantaris, Achillodynie, Periarthropathia humerosacpularis calcarea or Epikondylopathia humeri /radii get the shock wave therapy in our clinic as planned. During our study the...
Detailed Description
Patients with either Fascititis plantaris, Achillodynie, Periarthropathia humerosacpularis calcarea or Epikondylopathia humeri /radii get a shock wave therapy in our clinic of rheumatology as planned....
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Patients with:
- Fascititis plantaris,
- Achillodynie,
- Periarthropathia humerosacpularis calcarea or
- Epicondylopathia humeri /radii, who got the shock wave therapy.
- Exclusion criteria:
- Anticoagulation,
- Sepsis
Exclusion
Key Trial Info
Start Date :
July 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2015
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT01429883
Start Date
July 1 2011
End Date
January 1 2015
Last Update
June 3 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital
Zurich, Switzerland